Author

M. C. Abba

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 2 Research Focus:cancer & tumor microenvironment· 2 Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Assay:proteomics· 1 Approach:statistical model· 1

Frequent Co-Authors

M. Cooke· 2 shared M. G. Kazanietz· 2 shared D. M. Feldser· 1 shared D. Salyakina· 1 shared E. A. Mesri· 1 shared E. Lacunza· 1 shared F. Benavides· 1 shared J. Naipauer· 1 shared

Activity by Year

2020-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 18 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

M. Cooke

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Protein kinase C alpha is a central node for tumorigenic transcriptional networks in human prostate cancer

M. Cooke, X. Zhang, S. Zhang, P. Lal, R. E. Daniel, M. D. Feldman, M. C. Abba, M. G. Kazanietz

This study identifies PKC as a key driver of tumorigenic transcriptional networks in prostate cancer by showing its role in cell cycle, EMT, and immune checkpoint regulation.

bioRxiv · Apr 8, 2022Cancer Biology

A non-coding RNA network involved in KSHV tumorigenesis

J. Naipauer, M. E. Garcia Sola, D. Salyakina, S. Rosario, S. Williams, O. Coso, M. C. Abba, E. A. Mesri, E. Lacunza

The paper identifies a non-coding RNA network involving lncRNAs and miRNAs that modulate KSHV tumorigenesis pathways and develops therapeutic target signatures.

bioRxiv · Mar 5, 2021Cancer Biology

Requirement for PKC epsilon in KRAS-driven lung tumorigenesis

R. Garg, M. Cooke, S. Wang, F. Benavides, M. C. Abba, M. Cicchini, D. M. Feldser, M. G. Kazanietz

This study shows PKCε is required for KRAS-driven lung tumorigenesis and identifies it as a potential therapeutic target.

bioRxiv · Jun 26, 2020 · PreprintCancer Biology